Beam Therapeutics Inc. (BEAM)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 10:56AM EST. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 3.09B |
| Enterprise value | 2.17B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 33.06 |
| Price/book (mrq) | 4.32 |
| Enterprise value/revenue | 23.60 |
| Enterprise value/EBITDA | -7.23 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.68 |
| 52-week change 3 | -23.73% |
| S&P500 52-week change 3 | -8.00% |
| 52-week high 3 | 80.00 |
| 52-week low 3 | 27.77 |
| 50-day moving average 3 | 42.94 |
| 200-day moving average 3 | 46.49 |
Share statistics
| Avg vol (3-month) 3 | 815.66k |
| Avg vol (10-day) 3 | 665.04k |
| Shares outstanding 5 | 70.47M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 58.15M |
| % held by insiders 1 | 1.81% |
| % held by institutions 1 | 87.32% |
| Shares short (12 Jan 2023) 4 | 13.01M |
| Short ratio (12 Jan 2023) 4 | 14.78 |
| Short % of float (12 Jan 2023) 4 | 21.25% |
| Short % of shares outstanding (12 Jan 2023) 4 | 18.46% |
| Shares short (prior month 14 Dec 2022) 4 | 11.74M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2021 |
| Most-recent quarter (mrq) | 29 Sept 2022 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -171.86% |
Management effectiveness
| Return on assets (ttm) | -7.88% |
| Return on equity (ttm) | -40.23% |
Income statement
| Revenue (ttm) | 91.95M |
| Revenue per share (ttm) | 1.33 |
| Quarterly revenue growth (yoy) | 1,970.60% |
| Gross profit (ttm) | -180.29M |
| EBITDA | -145.19M |
| Net income avi to common (ttm) | -315.45M |
| Diluted EPS (ttm) | -3.59 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 1.09B |
| Total cash per share (mrq) | 15.9 |
| Total debt (mrq) | 178.5M |
| Total debt/equity (mrq) | 24.98 |
| Current ratio (mrq) | 4.64 |
| Book value per share (mrq) | 10.38 |
Cash flow statement
| Operating cash flow (ttm) | 93.55M |
| Levered free cash flow (ttm) | 54.13M |
© 2023 Yahoo. All rights reserved.
